Olga Kubassova, PhD[email protected]Nuclear MedicineHow medical imaging can accelerate drug developmentIt can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.January 21, 2019Page 1 of 1Top StoriesCTUse thin slices on CT for preop periampullary adenocarcinoma imagingPreoperative CT in patients with periampullary adenocarcinoma should include thin slices to reduce the chance of a terminated Whipple procedure.Practice ManagementPrivate equity acquisition rising in radiologyPractice ManagementMICI Q2: Confidence in growth of imaging as profit center remains highNuclear MedicineAc-225: From nuclear waste to cancer treatmentSponsor ContentRegister for a FREE Webinar March 19 @ 10 a.m. PT / 1 p.m. ET
